Sex differences in Parkinson’s disease

Kieburtz, 2013, Parkinson’s disease: evidence for environmental risk factors, Mov Disord, 28, 8, 10.1002/mds.25150 Pavon, 2010, Parkinson’s disease in women: a call for improved clinical studies and for comparative effectiveness research, Maturitas, 65, 352, 10.1016/j.maturitas.2010.01.001 Kowal, 2013, The current and projected economic burden of Parkinson’s disease in the United States, Mov Disord, 28, 311, 10.1002/mds.25292 Scott, 2000, Gender differences in Parkinson’s disease symptom profile, Acta Neurol Scand, 102, 37, 10.1034/j.1600-0404.2000.102001037.x Shulman, 2007, Gender differences in Parkinson’s disease, Gend Med, 4, 8, 10.1016/S1550-8579(07)80003-9 Ragonese, 2004, Risk of Parkinson disease in women: effect of reproductive characteristics, Neurology, 62, 2010, 10.1212/WNL.62.11.2010 Popat, 2005, Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease, Neurology, 65, 383, 10.1212/01.wnl.0000171344.87802.94 Benedetti, 2001, Hysterectomy, menopause, and estrogen use preceding Parkinson’s disease: an exploratory case-control study, Mov Disord, 16, 830, 10.1002/mds.1170 Rocca, 2008, Increased risk of parkinsonism in women who underwent oophorectomy before menopause, Neurology, 70, 200, 10.1212/01.wnl.0000280573.30975.6a Shulman, 2002, Is there a connection between estrogen and Parkinson’s disease?, Parkinsonism Relat Disord, 8, 289, 10.1016/S1353-8020(02)00014-7 Saunders-Pullman, 1999, The effect of estrogen replacement on early Parkinson’s disease, Neurology, 52, 1417, 10.1212/WNL.52.7.1417 Palacios, 2012, Caffeine and risk of Parkinson’s disease in a large cohort of men and women, Mov Disord, 27, 1276, 10.1002/mds.25076 Alves, 2009, Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study, J Neurol Neurosurg Psychiatry, 80, 851, 10.1136/jnnp.2008.168211 Haaxma, 2007, Gender differences in Parkinson’s disease, J Neurol Neurosurg Psychiatry, 78, 819, 10.1136/jnnp.2006.103788 Lyons, 1998, Gender differences in Parkinson’s disease, Clin Neuropharmacol, 21, 118 Zhu, 2013, Risk factors for hallucinations in Parkinson’s disease: results from a large prospective cohort study, Mov Disord, 28, 755, 10.1002/mds.25389 Leiknes, 2010, Caregiver distress associated with neuropsychiatric problems in patients with early Parkinson’s disease: the Norwegian ParkWest study, Acta Neurol Scand, 122, 418, 10.1111/j.1600-0404.2010.01332.x Calder, 1991, The prediction of stress in carers: the role of behaviour, reported self care and dementia in patients with idiopathic Parkinson’s disease, Int J Geriatr Psychiatry, 6, 737, 10.1002/gps.930061008 Lubomski, 2013, A cross-sectional study of clinical management, and provision of health services and their utilisation, by patients with Parkinson’s disease in urban and regional Victoria, J Clin Neurosci, 20, 102, 10.1016/j.jocn.2012.05.015 Jenkinson C, Fitzpatrick R, Peto V, et al. The Parkinson’s disease questionnaire PDQ-39 user manual (including PDQ-8 and the PDQ Summary Index). 2nd ed. Oxford; 2008. Marinus, 2002, Health related quality of life in Parkinson’s disease: a systematic review of disease specific instruments, J Neurol Neurosurg Psychiatry, 72, 241, 10.1136/jnnp.72.2.241 Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease, 2003, The unified Parkinson’s disease rating scale (UPDRS): status and recommendations, Mov Disord, 18, 738, 10.1002/mds.10473 Tomlinson, 2010, Systematic review of levodopa dose equivalency reporting in Parkinson’s disease, Mov Disord, 25, 2649, 10.1002/mds.23429 Solla, 2012, Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson’s disease, J Neurol Sci, 323, 33, 10.1016/j.jns.2012.07.026 Bucks, 2010, Coping processes and health-related quality of life in Parkinson’s disease, Int J Geriatr Psychiatry, 26, 247, 10.1002/gps.2520 Miller, 2010, Gender differences in Parkinson’s disease: clinical characteristics and cognition, Mov Disord, 25, 2695, 10.1002/mds.23388